September 6, 2012 (Vienna, Austria) — Older people with late-onset asthma have a different disease profile than older people who develop the disease at an earlier age and than younger people. One of ...
March 16, 2009 (Washington, DC) — Second-generation inhaled corticosteroids (ICS) and long-acting beta-2-agonist (LABA) bronchodilators, introduced into clinical practice in past decade, have ...
Melbourne lays claim to the unwanted title of being the epicenter of epidemic thunderstorm asthma (ETSA) worldwide, having experienced seven of the 26 recorded events. The most disastrous of those ...
– Verekitug, 100 mg dosed every 12 weeks, reduced AAER by 56% compared to placebo in patients with severe asthma – – Verekitug also delivered clinically meaningful improvements in lung function (FEV 1 ...
Individuals frequently seek medical care from clinics for issues related to asthma; the predominant symptoms for these patients will be cough, difficulty with breathing, and wheeze. One of the ...
Verekitug, 100 mg dosed every 12 weeks, reduced AAER by 56% compared to placebo in patients with severe asthma – – Verekitug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results